CRISPR/Cas9-Mediated Correction of the Sickle Mutation in Human CD34+ cells

CRISPR/Cas9-Mediated Correction of the Sickle Mutation in Human CD34+ cells Molecular Therapy 24, 1561 (september 2016). doi:10.1038/mt.2016.148 Authors: Megan D Hoban, Dianne Lumaquin, Caroline Y Kuo, Zulema Romero, Joseph Long, Michelle Ho, Courtney S Young, Michelle Mojadidi, Sorel Fitz-Gibbon, Aaron R Cooper, Georgia R Lill, Fabrizia Urbinati, Beatriz Campo-Fernandez, Carmen F Bjurstrom, Matteo Pellegrini, Roger P Hollis & Donald B Kohn

http://feeds.nature.com/~r/mt/rss/current/~3/MRalT56Fqus/mt.2016.148

Source: Molecular Therapy - September 28, 2016 Category: Genetics & Stem Cells Authors: Megan D Hoban Dianne Lumaquin Caroline Y Kuo Zulema Romero Joseph Long Michelle Ho Courtney S Young Michelle Mojadidi Sorel Fitz-Gibbon Aaron R Cooper Georgia R Lill Fabrizia Urbinati Beatriz Campo-Fernandez Carmen F Bjurstrom Matteo Pellegrini Roger P Ho Source Type: research

More News: Georgia Health